In silico modeling predicts drug sensitivity of patient-derived cancer cells

BACKGROUND: Glioblastoma (GBM) is an aggressive disease associated with poor survival. It is essential to account for the complexity of GBM biology to improve diagnostic and therapeutic strategies. This complexity is best represented by the increasing amounts of profiling (“omics”) data available du...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pingle, Sandeep C, Sultana, Zeba, Pastorino, Sandra, Jiang, Pengfei, Mukthavaram, Rajesh, Chao, Ying, Bharati, Ila Sri, Nomura, Natsuko, Makale, Milan, Abbasi, Taher, Kapoor, Shweta, Kumar, Ansu, Usmani, Shahabuddin, Agrawal, Ashish, Vali, Shireen, Kesari, Santosh
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030016/
https://ncbi.nlm.nih.gov/pubmed/24884660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-128
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares